Historical data from 1984 also show a marked increase in diabetes prevalence among patients with CRC [5], supporting the hyperinsulinemia hypothesis, which posits that high serum insulin levels may promote colon tumor growth and act as a mitogen, thereby increasing CRC risk [6]. The gene discussed is INS; the disease is colorectal carcinoma.